Quarterly report pursuant to Section 13 or 15(d)

Consolidated Condensed Statements of Income

v3.22.2
Consolidated Condensed Statements of Income - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jul. 02, 2022
Jun. 26, 2021
Jul. 02, 2022
Jun. 26, 2021
Income Statement [Abstract]        
Net revenue $ 15,321 $ 19,631 $ 33,674 $ 39,304
Cost of sales 9,734 8,425 18,843 17,244
Gross margin 5,587 11,206 14,831 22,060
Research and development 4,400 3,715 8,762 7,338
Marketing, general and administrative 1,800 1,599 3,552 2,927
Restructuring and other charges 87 346 (1,124) 2,555
Operating expenses 6,287 5,660 11,190 12,820
Operating income (loss) (700) 5,546 3,641 9,240
Gains (losses) on equity investments, net (90) 295 4,233 663
Interest and other, net (119) (96) 878 (252)
Income (loss) before taxes (909) 5,745 8,752 9,651
Provision for (benefit from) taxes (455) 684 1,093 1,229
Net income (loss) $ (454) $ 5,061 $ 7,659 $ 8,422
Earnings per share - Basic (in dollars per share) $ (0.11) $ 1.25 $ 1.87 $ 2.08
Earnings per share - Diluted (in dollars per share) $ (0.11) $ 1.24 $ 1.86 $ 2.06
Weighted average shares of common stock outstanding:        
Basic (shares) 4,100 4,049 4,095 4,053
Diluted (shares) 4,100 4,084 4,120 4,090